scholarly article | Q13442814 |
P2093 | author name string | T. Takahashi | |
Y. Obata | |||
T. Azuma | |||
O. Taguchi | |||
T. S. Doi | |||
P2860 | cites work | Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate transporters in mitochondria | Q24291715 |
Multiple nuclear factors interact with the immunoglobulin enhancer sequences | Q24296245 | ||
The NF-kappa B and I kappa B proteins: new discoveries and insights | Q24313579 | ||
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation | Q24642901 | ||
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 | ||
Establishment in culture of pluripotential cells from mouse embryos | Q27860625 | ||
A severe combined immunodeficiency mutation in the mouse | Q28274531 | ||
DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect | Q28307262 | ||
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB | Q28508403 | ||
Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B | Q28645847 | ||
Activation of interleukin-6 gene expression through the NF-kappa B transcription factor | Q28646310 | ||
Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes | Q29547355 | ||
Function and activation of NF-kappa B in the immune system | Q29547790 | ||
A general method for isolation of high molecular weight DNA from eukaryotes | Q29618192 | ||
Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal | Q29618196 | ||
DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide | Q34088506 | ||
Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family | Q34317095 | ||
Identification of a monoclonal antibody specific for a murine T3 polypeptide | Q34602051 | ||
The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: c-Rel, p50, and p65. | Q36125128 | ||
Identification of a functional NF-kappa B binding site in the murine T cell receptor beta 2 locus | Q36356965 | ||
RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter | Q36553588 | ||
The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain | Q36729399 | ||
RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B. | Q36812702 | ||
Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex | Q37349445 | ||
In vivo regulation of interleukin-2 receptor alpha gene transcription by the coordinated binding of constitutive and inducible factors in human primary T cells | Q37623891 | ||
Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor | Q37654865 | ||
Accessory cell signals involved in T-cell activation | Q37863466 | ||
Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice | Q38289217 | ||
Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens* | Q39858455 | ||
Biochemistry of B lymphocyte activation. | Q40812608 | ||
Transcriptional control of lymphoid development: lessons from gene targeting | Q41078445 | ||
Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation | Q41450875 | ||
The murine c-rel proto-oncogene encodes two mRNAs the expression of which is modulated by lymphoid stimuli. | Q41751983 | ||
Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses | Q42488424 | ||
Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors | Q42813665 | ||
The role of interleukin-6 in mucosal IgA antibody responses in vivo | Q45872747 | ||
Developmental expression of the mouse c-rel proto-oncogene in hematopoietic organs | Q52214145 | ||
Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression | Q62817899 | ||
Physiologic activation of T cells via the T cell receptor induces NF-kappa B | Q67901038 | ||
Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-kB-like response element | Q68246941 | ||
Differentiation of the mammalian hepatic primordium in vitro. I. Morphogenesis and the onset of haematopoiesis | Q69570285 | ||
Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule | Q70452024 | ||
Prevention of Mortality by in vivo Depletion of αβ T Cells in Murine Lethal Listeriosis and involvement of γδ T Cells in Bacterial Elimination | Q71819200 | ||
Simultaneous determination of cell surface antigens and apoptosis | Q72444774 | ||
Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells | Q72678853 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | NF-κB | Q411114 |
lymphocyte | Q715347 | ||
V-rel reticuloendotheliosis viral oncogene homolog A (avian) | Q15326089 | ||
P304 | page(s) | 953–961 | |
P577 | publication date | 1997-03-03 | |
P1433 | published in | Journal of Experimental Medicine | Q3186912 |
P1476 | title | NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses | |
P478 | volume | 185 |